W. Scott Simonet
Amgen Inc.
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Bone Metabolism and Diseases
Solid evidence · 1 supporting paper · latest 2008
Bone health and treatments
Solid evidence · 1 supporting paper · latest 2008
Osteomyelitis and Bone Disorders Research
Solid evidence · 1 supporting paper · latest 2008
Publications (1)
Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL
2008DOIPMID 19016581
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Amgen Inc.
Source: OpenAlex · retrieved 2026-09-29
Are you W. Scott Simonet? Sign in to claim this profile